Novo Holdings

Novo Holdings, established in 1999, is a Danish asset management firm based in Copenhagen. It serves as the investment arm of the Novo Nordisk Foundation, managing its assets and wealth. The company's primary focus is the life science sector, with a diversified portfolio comprising equities, bonds, real estate, infrastructure, and private investments. Novo Holdings maintains a significant influence on Novo Nordisk A/S and Novozymes A/S, ensuring these companies align with the Novo Group's visions and values. It also invests in early and growth-stage life science companies through its venture capital arm, Novo Ventures, which targets investments ranging from USD 5 million to USD 30 million.

Nis Bjørnholt Bak

Principal, Bioindustrial Investments

Jeroen Bakker

Partner, Seed Investments

Scott Beardsley

Managing Partner

Raymond Camahort

Partner, Novo Ventures (US) Inc

Lily Chang

Vice President, Growth Investments

Emmanuelle Coutanceau

Partner, Seed Investments

Kartik Dharmadhikari

Partner, Bioindustrial Investments

Thomas Dyrberg

Partner

Morten Graugaard Døssing

Partner, Seed Investments

Anna Fan

Senior Partner, Life Sciences Operating Committee, Venture Investments, Venture Investments (US) Inc

Thomas Grotkjær

Partner, Bioindustrial Investments

Kenneth Harrison Ph.D

Senior Partner

Kuang He Ph.D

Vice President, Seed Investments

Stephen van Helden

Principal, Bioindustrial Investments, Growth Investments

Deepa Hingorani

Partner, Planetary Health Investments

Karen Hong

Partner, Novo Ventures (US) Inc

Johan Hueffer

Senior Partner, Principal Investments

Amit Kakar

Managing Partner and Head of Novo Holdings Asia

Navjeewan Khosla

Partner, Novo Holdings Equity Asia

Max Klement

Principal, Venture Investments

Kasim Kutay

CEO

Abhijeet Lele

Senior Partner and Head of Principal Investments US

Jeffrey Low, MD

Principal, Growth Investments

Heather Ludvigsen

Senior Manager, Venture Investments

Joseph Markson Ph.D

Principal, Venture Investments

Peter Moldt

Partner

Daniel O'Connell

Partner, Venture Investments

Daniel Rasmussen

Principal, Seed Investments

João Ribas Ph.D

Principal, Seed Investments

Naveed Siddiqi

Senior Partner, Venture Investments

Eric Snyder

Partner, Venture Investments

Jim Trenkle

Partner, Venture Investments

Past deals in Dietary Supplements

Sylvan

Private Equity Round in 2025
Sylvan Inc. is a biotechnology company specializing in the production and distribution of mushroom spawns, including agaricus, pleurotus, and shiitake strains, as well as casing inoculum. Founded in 1946 and based in Kittanning, Pennsylvania, Sylvan has expanded its operations internationally, with production and sales facilities in multiple countries, including the Netherlands, France, Hungary, and South Africa. The company also offers disease control products and nutritional supplements for the mushroom industry. Additionally, Sylvan engages in solid-state fermentation technology, providing sustainable solutions for various sectors, including food, health, agriculture, and materials. With research and development facilities in the United States and France, Sylvan positions itself as an innovative partner for businesses seeking to enhance their growth through fungal biotechnology.

Elo Life Systems

Series A in 2024
Elo Life Systems is a biotechnology company dedicated to enhancing human health and wellness through innovative food solutions. The company aims to bridge the gap between food, agriculture, and health by employing precision gene editing and breeding technologies, genomics, and data analytics. Through partnerships with stakeholders across the food systems value chain, Elo focuses on improving agricultural productivity, meeting nutritional demands, and addressing food security challenges. By replacing sugar and artificial sweeteners with healthier alternatives, Elo Life Systems empowers individuals to enjoy their favorite foods while promoting healthier lifestyles.

Elo Life Systems

Series A in 2023
Elo Life Systems is a biotechnology company dedicated to enhancing human health and wellness through innovative food solutions. The company aims to bridge the gap between food, agriculture, and health by employing precision gene editing and breeding technologies, genomics, and data analytics. Through partnerships with stakeholders across the food systems value chain, Elo focuses on improving agricultural productivity, meeting nutritional demands, and addressing food security challenges. By replacing sugar and artificial sweeteners with healthier alternatives, Elo Life Systems empowers individuals to enjoy their favorite foods while promoting healthier lifestyles.

Kate Farms

Series C in 2022
Kate Farms, Inc. is a company that specializes in producing plant-based meal replacement shakes and tube feeding solutions for both adults and children. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company focuses on developing formulas that prioritize easy digestion and nutritional quality. Utilizing organic, plant-based ingredients, Kate Farms' products are free from synthetic additives and common allergens such as dairy, soy, gluten, corn, and nuts. The offerings are designed to cater to a wide range of dietary and medical needs, serving patients with severe chronic diseases as well as those with less serious medical issues. Products are available through a network of retail stores across the United States and online, with options for both prescription and over-the-counter purchase.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.